Canadian Association of Radiologists Journal
Volume 61, Issue 5 , Pages 265-270 , December 2010

Identification of Local Recurrence and Radiofibrosis by Computed Tomography Perfusion on Nasopharyngeal Carcinoma After Radiotherapy

  • Danke Su, MD

      Affiliations

    • Center of Image, Oncology Hospital, Guangxi Medical University, Nanning, Guangxi, P.R. China
    • Corresponding Author InformationAddress for correspondence: Danke Su, MD, Center of Image, Oncology Hospital, Guangxi Medical University, Nanning, Guangxi, P.R. China.
    • ,
  • Guanqiao Jin, MD

      Affiliations

    • Center of Image, Oncology Hospital, Guangxi Medical University, Nanning, Guangxi, P.R. China
    • ,
  • Dong Xie, MD

      Affiliations

    • Center of Image, Oncology Hospital, Guangxi Medical University, Nanning, Guangxi, P.R. China
    • ,
  • Younan Liu, MD

      Affiliations

    • Department of Pediatrics, Guangxi Medical University, Nanning, Guangxi, P.R. China

References 

  1. Altun M, Fandi A, Dupuis O, et al. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys. 1995;32:859–877
  2. Hwang HN. Nasopharyngeal carcinoma in the People's Republic of China: incidence, treatment, and survival rates. Radiology. 1983;149:305–309
  3. Roberts HC, Roberts TP, Lee TY, et al. Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability—report of two cases. AJNR Am J Neuroradiol. 2002;828–832
  4. Groell R, Kugler C, Aschauer M, et al. Quantitative perfusion parameters of focal nodular hyperplasia and normal liver parenchyma as determined by ele ctron beam tomography. Br J Radiol. 1995;68:1185–1189
  5. Hermans R, Lambin P, Van der Goten A, et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol. 1999;53:105–111
  6. Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in re ctal cancer with multise ction CT: initial observations. Radiology. 2005;234:785–792
  7. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9–19
  8. Miles KA. Perfusion CT for the assessment of tumour vascularity: which protocol?. Br J Radiol. 2003;76:S36–S42
  9. Dugdale PE, Miles KA, Bunce I, et al. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, a ctivity, and chemotherapeutic response. J Comput Assist Tomogr. 1999;23:540–547
  10. Yeung WT, Lee TY, Del Maestro RF, et al. In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors. J Neurooncol. 1992;14:177–187
  11. Sahani DV, Kalva SP, Hamberg LM, et al. Assessing tumor perfusion and treatment response in re ctal cancer with multise ction CT: initial observations. Radiology. 2005;234:785–792
  12. Willett CG, Boucher Y, di Tomaso E, et al. Dire ct evidence that the VEGF-specific antibody bevacizumab has antivascular effe cts in human re ctal cancer. Nat Med. 2004;10:145–147
  13. Kaiser WA. Dynamic magnetic resonance breast imaging using a double breast coil: an important step towards routine examination of the breast. Front Eur Radiol. 1990;7:40–67
  14. Buadu LD, Murakami JJ, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology. 1996;200:639–4
  15. Zagzag D, Goldenberg M, Brem S. Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model. AJR Am J Roentgenol. 1989;153:141–146
  16. Orel SG, Schnall MD, LiVolsi VA, et al. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology. 1994;190:485–493
  17. Geng JM, Yan MM, Cheng H, et al. Form and quantitative research of renal cell carcinoma vascularity. J Pract Oncol. 1996;14:59–62
  18. Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. Cancer Res. 1998;58:3598–3602
  19. Lang J, Heilek E. Anatomo-clinical findings on the ascending pharyngeal artery. Anat Anz. 1984;156:177–207
  20. Cenic A, Nabavi DG, Craen RA, et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol. 1999;20:63–73

PII: S0846-5371(09)00239-3

doi: 10.1016/j.carj.2009.11.009

Canadian Association of Radiologists Journal
Volume 61, Issue 5 , Pages 265-270 , December 2010

Article Tools

* Image Usage & Resolution